EMBO Press34m
HDAC6 deacetylates ENKD1 to regulate mitotic spindle behavior and corneal epithelial homeostasis
HDAC6 is upregulated in corneal diseases and causes ENKD1 deacetylation at lysine 98. Deacetylation of ENKD1 blocks its ...
The Scientist1d
Correcting the Mutation Behind a Genetic Eye Disease
Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...
Naples Daily News11d
Ocular surface disease: Proper diagnosis & treatment
Frantz EyeCare’s highly-trained specialists strive to provide the most advanced treatment for healthy eyes in all phases of ...
Fierce Biotech2d
NIH scientists develop eye drops that protect mice with eye disease from vision loss
A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...
Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment
Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.
Ophthalmology Times3d
Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease
Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...